-+ 0.00%
-+ 0.00%
-+ 0.00%

Seres Therapeutics Q1 EPS $3.75 Beats $0.12 Estimate

Benzinga·05/07/2025 11:03:29
Listen to the news
Seres Therapeutics (NASDAQ:MCRB) reported quarterly earnings of $3.75 per share which beat the analyst consensus estimate of $0.12 by 3025 percent. This is a 1488.89 percent increase over losses of $(0.27) per share from the same period last year.